Analysts’ updated eps estimates for Thursday, September 7th:

Aaron’s, (NYSE:AAN) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $54.00 target price on the stock.

Ashford Hospitality Trust (NYSE:AHT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ashford Hospitality Trust Inc is a self advised Maryland corporation and real estate investment trust organized to pursue opportunities in the lodging industry. Initial assets consist of six hotels comprised of four Embassy Suites and two Radisson properties as well as eight asset management and consulting agreements. “

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $85.00 target price on the stock. The analysts wrote, “Alnylam announced today that dosing of fitusiran, in development for Hemophilia, has been suspended in all clinical trials. A patient death tied to a thrombotic event was reported in ongoing Phase 2 OLE trial and FDA has issued a clinical hold. Alnylam had just initiated a Phase 3 program in Jul 2017. The incident raises questions around safety margin for the drug. Fitusiran is intended to increase thrombin levels closer to normal range. Concerns, however, have been raised around risk of thrombosis if thrombin levels are too high, particularly when used w/ on-demand factor or bypassing agents. Based on available clinical data, we believe fitusiran allows for better control of Hemophilia, but patients and physicians may have a narrower safety window when managing bleeds. Our bias is Alnylam and FDA will reach agreement on a protocol to more closely monitor patients and that clinical development will resume over next 3-6 months. We continue to believe in long-term value of RNAi, but acknowledge greater risk than we anticipated around fitusiran. We have reduced our fitusiran estimates to reflect delayed launch and slower market penetration.””

Alstom ADR (OTCMKTS:ALSMY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Alstom SA develops and markets systems, equipment and services for the railway sector. Its product includes bogies, traction systems, electrification, track laying and urban integrated solution. It also offers services such as parts and repairs, maintenance, customisation, modernisation and support services. Alstom SA is headquartered in France. “

AnaptysBio (NASDAQ:ANAB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $34.00 price target on the stock. According to Zacks, “AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California. “

ANTA SPORTS PRODUC HKD0.10 (NASDAQ:ANPDF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ANTA Sports Products Limited designs, develops, manufactures, trades, distributes, and markets sportswear in the People’s Republic of China. The company’s products include footwear, apparel, and accessories for professionals and the general public. ANTA Sports Products Limited is headquartered in Jinjiang City, the People’s Republic of China. “

Athersys (NASDAQ:ATHX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $2.25 price target on the stock. According to Zacks, “Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company’s lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the treatment of obesity. The company is also developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). Athersys is developing MultiStem(r), its patented, adult-derived “off the shelf” stem cell product platform, for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. “

AveXis (NASDAQ:AVXS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Company’s product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant mortality. AveXis, Inc. is headquartered in Bannockburn, Illinois. “

Boohoo.Com Plc (NASDAQ:BHOOY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $65.00 price target on the stock. According to Zacks, “boohoo.com plc designs, sources, markets and sells clothing, shoes and accessories through the www.boohoo.com Website. It operates primarily in the United Kingdom, Europe and internationally. The company’s brand name consists of boohooMan. boohoo.com plc is headquartered in Manchester, the United Kingdom. “

Bob Evans Farms (NASDAQ:BOBE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BOB EVANS FARMS, INC. is divided into two principal industry segments: the food products segment and the restaurant segment. The company owns and operates restaurants, including Bob Evans Restaurants, Owens Family Restaurants, Bob Evans small-town Restaurants and Cantina Del Rio Mexican restaurants. They also produce fresh and fully-cooked sausage products and fresh, deli-style salads which are distributed primarily to grocery stores in the Midwest, Southwest and Southeast. “

Bank of Commerce Holdings (CA) (NASDAQ:BOCH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $12.00 target price on the stock. According to Zacks, “Bank of Commerce Holdings is a financial service holding company that owns Redding Bank of Commerce, Roseville Bank of Commerce, a division of Redding Bank of Commerce and Bank of Commerce Mortgage, an affiliate of Redding Bank of Commerce and Roseville Bank of Commerce. “

Sierra Bancorp (NASDAQ:BSRR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $28.00 target price on the stock. According to Zacks, “Sierra Bancorp is the bank holding company for the Bank of the Sierra. The Bank of the Sierra is the largest independent bank headquartered in the South Valley, and operates branch offices as well as real estate centers, agricultural credit centers and a bank card center. “

The Cheesecake Factory (NASDAQ:CAKE) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $46.00 target price on the stock.

China National Mat (NASDAQ:CASDY) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $9.00 target price on the stock. According to Zacks, “China National Building Material Company Limited (CNBM) is an investment holding company principally engaged in the production and sale of cement. The Company operates its business through six segments. The Cement segment is engaged in the production and sale of cement. The Concrete segment is engaged in the production and sale of concrete. The Lightweight Building Materials segment is engaged in the production and sale of lightweight building materials. The Glass Fiber and Composite Materials segment is engaged in the production and sale of glass fiber and composite materials. The Engineering Services segment is engaged in the provision of engineering services to glass and cement manufacturers and equipment procurement. The others segment is engaged in merchandise trading business and others. “

Caseys General Stores (NASDAQ:CASY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Casey’s General Stores, Inc. operate convenience stores under the name Casey’s General Store in Midwestern states, primarily Iowa, Missouri and Illinois. The stores carry a broad selection of food (including freshly prepared foods such as pizza, donuts and sandwiches), beverages, tobacco products, health and beauty aids, automotive products and other non-food items. In addition, all stores offer gasoline for sale on a self-service basis. “

Coeur Mining (NYSE:CDE) was downgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a market perform rating.

Chegg (NYSE:CHGG) had its buy rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $17.00 target price on the stock.

Cummins (NYSE:CMI) had its hold rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $165.00 target price on the stock.

Cairn Homes PLC (LON:CRN) had its outperform rating reiterated by analysts at Credit Suisse Group.

CSX (NASDAQ:CSX) had its hold rating reiterated by analysts at Stifel Nicolaus. The firm currently has a $55.00 price target on the stock, down from their previous price target of $57.00.

Diana Shipping inc. (NYSE:DSX) had its hold rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $4.50 target price on the stock.

Expedia (NASDAQ:EXPE) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $175.00 price target on the stock.

Fiat Chrysler Automobiles N.V. (NYSE:FCAU) had its hold rating reissued by analysts at Deutsche Bank AG.

GoPro (NASDAQ:GPRO) had its price target raised by J P Morgan Chase & Co from $13.00 to $15.00. The firm currently has an overweight rating on the stock.

At Home Group (NASDAQ:HOME) had its equal weight rating reissued by analysts at Morgan Stanley. The firm currently has a $24.00 target price on the stock, up from their previous target price of $20.00.

Kimberly-Clark Corporation (NYSE:KMB) had its hold rating reiterated by analysts at Jefferies Group LLC. They currently have a $119.00 target price on the stock.

Coca-Cola Company (The) (NYSE:KO) had its hold rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $47.00 price target on the stock.

Kohl’s Corporation (NYSE:KSS) had its neutral rating reaffirmed by analysts at Robert W. Baird. They currently have a $43.00 target price on the stock.

Luxoft Holding (NYSE:LXFT) was downgraded by analysts at Credit Suisse Group from a neutral rating to an underperform rating.

Mattel (NASDAQ:MAT) had its hold rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $17.00 target price on the stock.

Micro Focus International plc (LON:MCRO) had its neutral rating reissued by analysts at Citigroup Inc.. They currently have a GBX 2,430 ($31.38) target price on the stock.

Monster Beverage Corporation (NASDAQ:MNST) had its outperform rating reissued by analysts at Credit Suisse Group. The firm currently has a $61.00 target price on the stock.

Pacira Pharmaceuticals (NASDAQ:PCRX) had its buy rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $59.00 price target on the stock.

Rent-A-Center (NASDAQ:RCII) had its hold rating reiterated by analysts at Jefferies Group LLC. They currently have a $12.00 target price on the stock.

Ryerson Holding Corporation (NYSE:RYI) had its hold rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $9.25 target price on the stock.

J P Morgan Chase & Co assumed coverage on shares of Standard Life Plc (LON:SLA). J P Morgan Chase & Co issued an overweight rating and a GBX 540 ($6.97) price target on the stock.

Sonoco Products (NYSE:SON) had its hold rating reissued by analysts at Jefferies Group LLC. They currently have a $48.00 target price on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its outperform rating reaffirmed by analysts at William Blair.

Sarepta Therapeutics (NASDAQ:SRPT) had its overweight rating reaffirmed by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $55.00 price target on the stock, up from their previous price target of $50.00.

Sarepta Therapeutics (NASDAQ:SRPT) had its buy rating reiterated by analysts at SunTrust Banks, Inc.. The firm currently has a $56.00 price target on the stock.

tronc (NASDAQ:TRNC) had its buy rating reiterated by analysts at Noble Financial.

Walgreens Boots Alliance (NASDAQ:WBA) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $95.00 price target on the stock.

WisdomTree Investments (NASDAQ:WETF) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $14.00 price target on the stock.

Windstream Holdings (NYSE:WIN) had its hold rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $2.50 target price on the stock.

Zpg Plc (LON:ZPG) had its price target raised by Credit Suisse Group from GBX 440 ($5.68) to GBX 460 ($5.94). The firm currently has an outperform rating on the stock.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.